|
ANTITRUST
|
| |
|
Antitrust class action settlements often involve large settlement funds
and complex benefit calculations. CAA has the analytical and financial expertise to manage
settlement funds of $100 million and more.
Below are examples of
Class Action Administration's experience in this challenging field.
Unless otherwise noted, these cases settled prior to trial. The parties cooperated to achieve
a mutually agreeable outcome. The fact that a settlement was reached should not be
construed as an admission of wrongdoing on the part of the defendants.
|
|
|
In re Wellbutrin SR Direct Purchaser Litigation
Plaintiffs alleged that the Defendant improperly obtained patent protection
of the drug Wellbutrin®, and then used the patents to delay the availability of lower-cost
generic drugs. CAA provided the following services:
|
- Placed published notice in a pharmaceutical trade publication
|
- Printed & mailed the Notice of Pendency
|
|
- Answered class member inquiries
|
- Processed opt-outs
|
|
|
|
Stop and Shop Supermarket Co. v. SmithKline Beecham
Plaintiffs alleged that GlaxoSmithKline (GSK) improperly obtained patent protection
of the drug Paxil®, and that GSK then used the patents to delay the availability of lower-cost
generic drugs. CAA provided the following services:
|
- Acted as escrow agent for $100 million settlement fund
|
- Placed published notice
|
|
- Printed & mailed notice and claim form
|
- Created website
|
|
- Answered class member inquiries
|
- Processed claims
|
|
- Analyzed GSK sales data and claimants' purchase data to determine
benefit amounts
|
- Disbursed settlement benefits by wire and by check
|
|
|
|
Ryan-House v. GlaxoSmithKline
Plaintiffs alleged that GlaxoSmithKline (GSK) improperly obtained patent protection
of the drug Paxil®, and that GSK then used the patents to delay the availability of lower-cost
generic drugs. CAA provided the following services:
|
- Placed published notice
|
- Printed & mailed notice and claim form
|
|
- Answered class member inquiries
|
- Processed claims
|
|
- Analyzed GSK sales data and claimant purchase data to determine benefit
amounts
|
- Disbursed benefits by wire and by check from $62.5 million settlement fund
|
|
|
|
Contact us to learn more about how CAA can assist you
with your next class action settlement.
|
|